These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 1470108)

  • 1. [Surgical versus nonsurgical therapy of fatal tachyarrhythmias].
    Yagi Y; Shiikawa A; Nakano H; Hayashi K; Akimoto T; Endo M; Koyanagi H
    Nihon Geka Gakkai Zasshi; 1992 Sep; 93(9):1020-3. PubMed ID: 1470108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arrhythmogenic right ventricular cardiomyopathy. Antiarrhythmic drugs, catheter ablation, or ICD?
    Wichter T; Paul TM; Eckardt L; Gerdes P; Kirchhof P; Böcker D; Breithardt G
    Herz; 2005 Mar; 30(2):91-101. PubMed ID: 15875097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ventricular arrhythmia following alcohol septal ablation for obstructive hypertrophic cardiomyopathy.
    Noseworthy PA; Rosenberg MA; Fifer MA; Palacios IF; Lowry PA; Ruskin JN; Sanborn DM; Picard MH; Vlahakes GJ; Mela T; Das S
    Am J Cardiol; 2009 Jul; 104(1):128-32. PubMed ID: 19576333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of ventricular fibrillation rather than ventricular tachycardia predicts tachyarrhythmia recurrences in patients with idiopathic dilated cardiomyopathy and implantable cardioverter defibrillator for secondary prophylaxis.
    Rolf S; Haverkamp W; Borggrefe M; Breithardt G; Bocker D
    Europace; 2009 Mar; 11(3):289-96. PubMed ID: 19095687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy: clinical presentation, risk stratification and results of long-term follow-up.
    Pezawas T; Stix G; Kastner J; Schneider B; Wolzt M; Schmidinger H
    Int J Cardiol; 2006 Mar; 107(3):360-8. PubMed ID: 16503259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The radiofrequency catheter ablation of ventricular tachycardia].
    Adragão P; Parreira L; Morgado F; Almeida M; Mesquita A; Machado FP; Martins D; Bonhorst D; Seabra-Gomes R
    Rev Port Cardiol; 1996 Feb; 15(2):119-28, 100. PubMed ID: 8645475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catheter ablation for the treatment of electrical storm in patients with implantable cardioverter-defibrillators: short- and long-term outcomes in a prospective single-center study.
    Carbucicchio C; Santamaria M; Trevisi N; Maccabelli G; Giraldi F; Fassini G; Riva S; Moltrasio M; Cireddu M; Veglia F; Della Bella P
    Circulation; 2008 Jan; 117(4):462-9. PubMed ID: 18172038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short- and long-term success of substrate-based mapping and ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia.
    Verma A; Kilicaslan F; Schweikert RA; Tomassoni G; Rossillo A; Marrouche NF; Ozduran V; Wazni OM; Elayi SC; Saenz LC; Minor S; Cummings JE; Burkhardt JD; Hao S; Beheiry S; Tchou PJ; Natale A
    Circulation; 2005 Jun; 111(24):3209-16. PubMed ID: 15956125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catheter ablation of ventricular tachycardia using radiofrequency techniques in patients without structural heart disease.
    Klein LS; Miles WM; Hackett FK; Zipes DP
    Herz; 1992 Jun; 17(3):179-89. PubMed ID: 1639337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Short-term and long-term outcome of left heart function after cardioverter defibrillator implantation].
    Takeichi K; Kasanuki H; Ohnishi S; Endoh Y; Hosoda S
    J Cardiol; 1996 Nov; 28(5):277-86. PubMed ID: 8953401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The automatic implantable cardioverter defibrillator--clinical experience in patients with life-threatening ventricular tachyarrhythmias].
    Shiikawa A; Koyanagi H; Endo M; Yagi Y; Nakano H; Hayashi K; Yamazaki K; Akimoto T
    Nihon Kyobu Geka Gakkai Zasshi; 1991 Mar; 39(3):294-300. PubMed ID: 2051086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
    Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
    Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic myocardial infarction is a substrate for bradycardia-induced spontaneous tachyarrhythmias and sudden death in conscious animals.
    Killingsworth CR; Walcott GP; Gamblin TL; Girouard SD; Smith WM; Ideker RE
    J Cardiovasc Electrophysiol; 2006 Feb; 17(2):189-97. PubMed ID: 16533257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of nonsustained and sustained ventricular tachyarrhythmias in patients with an implantable cardioverter defibrillator.
    Zhou X; Gunderson BD; Olson WH;
    J Cardiovasc Electrophysiol; 2004 Jan; 15(1):14-20. PubMed ID: 15028067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiofrequency ablation of the ventricular tachycardia with arrhythmogenic right ventricular cardiomyopathy using non-contact mapping.
    Yao Y; Zhang S; He DS; Zhang K; Hua W; Chu J; Pu J; Chen K; Wang F; Chen X
    Pacing Clin Electrophysiol; 2007 Apr; 30(4):526-33. PubMed ID: 17437577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Programmed electrical stimulation of the heart in relation to left ventricular contractility in ischemic heart disease].
    Wnuk-Wojnar A; Drzewiecki J; Gasior Z; Jaklik A; Buszman P; Dabrowski A; Kołodziej P; Kopeć P; Marciniak W; Pasyk S
    Kardiol Pol; 1990; 33(9-10):4-9. PubMed ID: 2074645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Current management of patients with ventricular tachycardia].
    Puljević D; Buljević B; Milicić D
    Lijec Vjesn; 2001; 123(7-8):191-200. PubMed ID: 11729615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Long-term outcome of pharmacological and nonpharmacological treatment for ventricular arrhythmias].
    Ohnishi S; Kasanuki H
    J Cardiol; 2000 Mar; 35 Suppl 1():75-84. PubMed ID: 10834174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiofrequency catheter ablation of idiopathic ventricular tachycardia and symptomatic premature ventricular contraction originating from valve annulus.
    Wu XY; Liang ZG; Tan Z; Gu HY; Zhang S; Li WM
    Chin Med J (Engl); 2008 Nov; 121(22):2241-5. PubMed ID: 19080325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term efficacy of catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Dalal D; Jain R; Tandri H; Dong J; Eid SM; Prakasa K; Tichnell C; James C; Abraham T; Russell SD; Sinha S; Judge DP; Bluemke DA; Marine JE; Calkins H
    J Am Coll Cardiol; 2007 Jul; 50(5):432-40. PubMed ID: 17662396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.